NCT04809922Completed
Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation
Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation in a Real-World Cohort of Patients; BASEL Wearable Study
Source: ClinicalTrials.gov · Last updated 1 Mar 2024
Brief summary (registry, in English)
Atrial fibrillation (AF) is the most common cardiac arrhythmia. This study is to assess the heart rhythm device accuracy of five cardiac wearable devices (Apple Watch, Kardia Mobile/Kardia Mobile 6L, Fitbit Sense, Samsung Galaxy Watch 3 and Withings Scanwatch, Withings SA, Model Number: HWA09) and its detection algorithms in identifying AF compared to a nearly simultaneously acquired physician-interpreted 12-lead ECG in a real world cohort of patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 312 (actual)
- First submitted
- 18 Mar 2021
- Start date
- 6 Apr 2021
- Primary completion date
- 31 Jan 2024
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Atrial fibrillation
- NCT number
- NCT04809922
What you commit to
- Study type: Observational
- Participants enrolled: 312
- From 6 Apr 2021 to the primary completion date, 31 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving hemodialysis through arteriovenous fistula in the upper extremities
Other
- Use of a radial artery graft for coronary artery bypass grafting
- Tattoos located on the skin of the wrist or forearm where wearable device will be placed
- Patients with inability to communicate and comply with all study requirements
- Patients who refused to participate in the trial
Who the study is looking for
- All consecutive patients undergoing electrophysiological study, pacemaker or implantable defibrillator (ICD) implantation or electric cardioversion at the University Hospital Basel are eligible for study participation and will be asked to participate
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Cardiology, University Hospital Basel Coordinator of this site? Confirm its status | Basel | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.